Patients receive new BIOTRONIK cardiac resynchronisation therapy implantable defibrillators that grant MRI access and reduce shocks
BIOTRONIK has announced the first worldwide implantations of its new ICD and CRT-D series of implantable cardioverter-defibrillators and cardiac resynchronisation therapy defibrillators.
With Sentus quadripolar leads and the Inventra series, BIOTRONIK offers the only devices for patients with heart failure worldwide that are approved for MRI use. The quadripolar Sentus lead eases the implantation process by giving physicians access to challenging vessels. With CE approval in early July, BIOTRONIK\'s new implantable defibrillator series includes the industry\'s-first quadripolar left-ventricular leads to be approved for MRI use.
BIOTRONIK is the first and only company to offer heart failure patients cardiac resynchronisation therapy devices and leads that can undergo MRI scans. As patients age, they may develop comorbidities, and MRI scans can be critical in diagnosing conditions like stroke, brain tumours or orthopaedic conditions.
Many heart failure patients are very ill and shocks put stress on the body and mind. By choosing a device with unique algorithms that reduce shocks, I am able to give my patients peace of mind and restore their sense of safety
"My ICD and heart failure patients are frequently indicated for MRI scans to diagnose potential comorbidities," said Dr Antonio Curnis, of the Spedali Civili Hospital in Brescia, Italy, who implanted a new BIOTRONIK ProMRI Inventra HF-T and Sentus quadripolar lead in a 73-year-old patient with congestive heart failure.
"With BIOTRONIK devices, I know I can give my patients high-quality therapy and broad access to diagnostics."
In addition to ProMRI technology, the new BIOTRONIK ICDs and CRT-Ds reduce inappropriate shocks with MorphMatch morphology detection criteria and anti-tachycardia pacing (ATP) optimisation. While delivering shocks at the right time can save patients\' lives, shocks should be minimised to appropriately control arrhythmias, improve patients\' quality of life, and increase device longevity.
Dr Werner Jung of the Schwarzwald-Baar Clinic in Villingen Schwenningen, Germany, successfully implanted a 72-year-old heart failure patient with a new ProMRI CRT-D device.
Dr Jung said: "Many heart failure patients are very ill and shocks put stress on the body and mind. By choosing a device with unique algorithms that reduce shocks, I am able to give my patients peace of mind and restore their sense of safety."
BIOTRONIK has included its Closed Loop Stimulation (CLS) technology in ICDs for the first time. CLS helps patients experience the most-natural rate adoption possible by utilising their neurological information. It is the only system that allows pacemakers, and now ICDs, to react naturally to patients\' physical as well as mental activity or stress.